AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2019
Mar 27, 2019
34491_dirs_2019-03-27_8cf49a45-e996-4bdb-8757-3ce234261ee5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-03-27
Reporting Person: ANSARI ABID (Chief Financial Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $1.20 | 2026-08-10 | Common Stock (140535) | Direct | |
| Employee Stock Option (Right to Buy) | $1.18 | 2027-03-23 | Common Stock (14053) | Direct | |
| Employee Stock Option (Right to Buy) | $11.98 | 2028-09-27 | Common Stock (140535) | Direct |
Footnotes
F1: The option vests as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three-month period over the following 36 months.
F2: The option vests as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the following 36 months.
F3: The option vests as to 25% of the underlying shares on September 28, 2019 and vests in equal installments at the end of each successive three-month period over the following 36 months.